In March 2012, the Centers for Disease Control and Prevention (CDC) reported a growing number of "severe and extensive" cases of hand, foot, and mouth disease (HFMD) attributed to coxsackievirus A6 (CVA6). 1 Over the past 5 years, CVA6 has also been implicated in HFMD outbreaks in Finland, France, Spain, India, Taiwan, Japan, Singapore, China, and Boston, Massachusetts. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] The atypical cutaneous features characterizing the 2011-2012 North American CVA6-associated HFMD outbreak have not been clearly defined.
HFMD was first described by C.R. Robinson as a self-limited febrile illness characterized by "pharyngeal lesions and vesicular exanthem" affecting young children in a Toronto suburb in the summer of 1957. 12 Since that report, HFMD has become a widely recognized childhood exanthem, representing a frequent and characteristic manifestation of enterovirus infections. Classic HFMD consists of fever, oral erosions, and gray-white, oval vesicles on the hands, feet, and buttocks. 13, 14 Children aged ,5 years are most often affected with transmission occurring via fecal-oral route, vesicle fluid, or respiratory secretions. 15 Coxsackievirus A16 (CVA16) and enterovirus 71 are the 2 most commonly reported causes of HFMD. 16, 17 CVA16 has traditionally been considered the most frequent cause of HFMD in the United States. 17 Enterovirus 71 has been responsible for a number of outbreaks of HFMD associated with severe neurologic complications in Asia. 18, 19 The purpose of this multi-institutional, retrospective study was to better define the more severe, varied, and extensive dermatologic manifestations of the CVA6-associated outbreak in North America.
METHODS
We performed a multi-institutional retrospective case series of pediatric patients between the ages of 0 and 18 years evaluated by pediatric dermatologists at 7 institutions (University of California, San Francisco [UCSF]; New York University; Washington University in St Louis; The Hospital for Sick Children, Toronto; Children's Hospital Boston; Stony Brook University in collaboration with North Shore-Long Island Jewish Health System Laboratories; and Yale University) from July 2011 to June 2012 with atypical presentations of HFMD. Patients were identified through a search of electronic health records and photo archives at each institution. Patients were included if infection with CVA6 was confirmed by nucleotide sequencing of samples from oropharynx, skin, blood, or stool or if they met clinical case criteria for atypical or severe HFMD. The clinical inclusion criteria were predetermined by the lead authors based on initial experience with this outbreak. Two categories of clinical case criteria needed to be fulfilled for inclusion: (1) features suggestive of HFMD and (2) unusual extent or morphology. Features suggestive of HFMD were defined as an enanthem characteristic of HFMD (small vesicles and erosions on the oral mucosa), exanthem with features suggestive of HFMD (gray-white, oval vesicles on the hands, feet, and buttocks), or history of exposure to HFMD 2 to 14 days before disease onset. To meet the criteria for unusual morphology or extent of dermatologic findings, patients needed to have at least 1 of the following: HFMD exanthem involving .5% of the body surface area (BSA); erosions, vesicles (fluid filled blister ,1 cm) and/or bullae (fluid filled blister .1cm) with acrofacial accentuation; purpuric, petechial, or hemorrhagic lesions; coalescing papules symmetrically distributed on the face, arms, and legs with relative sparing of the trunk similar to Gianotti-Crosti; or large bullae (.2 cm). Patients were excluded if the presentation could be explained by another specific illness such as, but not limited to, varicella or herpes simplex virus (HSV) infection, bullous impetigo, uncomplicated atopic dermatitis (AD), contact dermatitis, or other bullous diseases, or if the exanthem and enanthem were consistent with classic HFMD with ,5% BSA involved. Two investigators (EM, IJF) reviewed data collection forms and available photographs for all cases. Institutional review board approval was obtained from UCSF as the coordinating board and from each participating institution as required.
A standardized data collection form was used to record epidemiologic and clinical data including age, gender, ethnicity, race, school or day-care participation, sick contacts, travel history, history of skin conditions, disease onset and duration, systemic symptoms, relevant laboratory results, treatment received, and whether they were managed as an inpatient or outpatient. The morphology and distribution of the eruption were assessed in detail including primary skin lesion types and location, extent (BSA), secondary features, nail changes, and oropharyngeal involvement. We also recorded whether the eruption was concentrated in areas previously or currently affected by AD (similar to eczema herpeticum), localized to an area of previous skin injury, or appeared similar to Gianotti-Crosti. Enterovirus detection was done by either 1-step real-time reverse transcriptase polymerase chain reaction (PCR) or nucleic acid sequence-based amplification using the NucliSens EasyQ EV assay (bioMerieux, Durham, NC). For the enterovirus-positive samples, when available, enterovirus type was determined by sequencing at the CDC or the California Department of Public Health. 20 Data were compiled and analyzed by using Excel and SAS version 9.2 (SAS Institute, Cary, NC). Characteristics were examined for 3 subsets of patients: (1) patients with and without AD; (2) patients PCR-positive for CVA6 versus patients not tested for CVA6; and (3) patients classified into 3 age groups (,1, 1-5, .5 years). The Mann-Whitney test was used to compare differences in medians of a continuous characteristic between groups, and the Fisher's exact test was used to compare differences in percentages of a categorical characteristic between groups.
RESULTS
Eighty patients from 7 institutions were included in the analysis (14 from UCSF, 13 from New York University, 13 from Washington University, 13 from The Hospital for Sick Children, 11 from Children's Hospital Boston, 10 from Stony Brook University, and 6 from Yale University). Seventeen patients met the virologic case criteria, and 63 met the clinical case criteria. The median age of the patients was 1.5 years (range 4 months-16 years; Table 1 ). Males and females were equally represented. The majority of patients were evaluated and managed in the outpatient setting, with only 13% hospitalized. Most patients presented in the spring and early summer of 2012 (Fig 1) . Fortythree (54%) patients had a recorded exposure (21 day care, 11 family, 8 school, and 3 other) to HFMD.
The primary dermatologic finding was an eruption consisting of vesicles, bullae, or erosions. This presentation was seen in all but 1 patient who presented with papules concentrated on the extremities, including palms and soles, perioral face, and buttocks.
The eruption affected the extremities in all patients and usually involved the hands and feet; lesions were also frequently observed on the face (62/ 79; 79%), torso (45/80; 56%), and buttocks/groin (55/72; 76%; Table 2 , Figs 2, 3, 4, 5, and 6). Forty-two (61%) of 69 children with available data had .10% BSA involved. Cutaneous morphologies included relatively monomorphous erosions and vesicles concentrated in areas previously or currently affected by AD, similar to eczema herpeticum (44/80; 55%; Fig 3) , hemorrhagic or purpuric lesions (13/78; 17%; Fig 4) , and an eruption similar to Gianotti-Crosti (28/76; 37%). Fourteen patients had lesions in areas of skin injury including sunburn (Fig 5) , irritant dermatitis (diaper, thumb-sucking, perioral, and medication induced), tinea pedis, and lacerations/scars. Two patients had large bullae (Fig 6) . Intraoral erosions were identified in 39 of 77 (51%) patients. Of patients with available specific follow-up data, 9/38 (24%) had nail changes 4 to 6 weeks after initial presentation and 14 of 27 (52%) had desquamation of their a Percentages were rounded and do not add up to 100%.
FIGURE 1
Number of atypical HFMD cases by month of presentation (N = 79).
ARTICLE palms or soles 1 to 3 weeks after initial presentation.
Infants ,1 year old were significantly more likely to have bullae (Fig 6) than older children (38% of patients aged ,1 year vs 7% of patients aged 1-5 years vs 18% of patients aged .5 years; P = .039). Older children were more likely to have hemorrhagic or purpuric lesions (Fig 4; 8% , 1 year vs 12% 1-5 years vs 43% .5 years; P = .021) and nail changes (33% ,1 year vs 14% 1-5 years vs 75% .5 years, P = .022). There were no other significant morphologic differences between age groups.
Forty-nine of 79 (62%) patients had a preexisting skin condition, 40 (82%) of whom had a history of AD. Patients with AD were significantly more likely to have an eczema herpeticum-like presentation (81% of patients with AD, versus 24% of patients without AD; P , .0001) (Figure 3 ). There were no other significant differences between patients with and without AD. 
FIGURE 2
A 13-year-old with facial erosions and vesicles who had confirmed CVA6 infection.
termed "eczema coxsackium," (3) an eruption similar to Gianotti-Crosti, and (4) a petechial or purpuric eruption ( Table 4 ).
The most common dermatologic presentation in our sample was widespread vesicles, bullae, and/or erosions. Classically, the vesicular exanthem of HFMD is restricted to the hands, feet, and occasionally the buttocks. 10, 13, 14, 19, 21, 22 The accompanying enanthem consists of small vesicles and erosions on the oral mucosa. 12, 13 The exanthem in our series differed by commonly involving the perioral area, extremities, and torso in addition to more classic HFMD locations. Other recent studies have also emphasized the perioral distribution of CVA6-associated disease. 10 A distribution similar to Gianotti-Crosti was documented in one-third of the patients in our study, with lesions involving the cheeks, extensor surfaces of the extremities, and buttocks, but sparing the trunk. 30 Classic GianottiCrosti is characterized by monomorphous lichenoid papules and/or papulovesicles, whereas the eruption associated with this outbreak was more often papulovesicular with prominent erosions. Epstein-Barr virus and hepatitis B virus are the most commonly reported causes of GianottiCrosti, 30 but enteroviruses such as coxsackieviruses A16, B4, and B5 have also been implicated. 31 A petechial and purpuric rash was documented in 17% of our patients, most often in those aged .5 years and most frequently found on acral sites. Petechial and purpuric eruptions are a known cutaneous manifestation of enteroviral infections, 32, 33 and CVA6 infection should be added to the differential diagnosis of acral purpura, particularly in the setting of a community outbreak.
FIGURE 3
Eczema coxsackium: A toddler with confirmed CVA6 infection who had erosions localized to areas of AD.
FIGURE 4
A 16-year-old with confirmed CVA6 infection who had purpuric papules and vesicles on the feet.
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Delayed cutaneous features of this exanthem include nail changes and desquamation of the palms and soles, which typically occurred weeks after the resolution of the vesiculobullous eruption. Onychomadesis (separation of the proximal nail plate from the nail matrix and nail bed), and Beau' s lines (horizontal ridging of the nail plate) were a common feature of CVA6 infection in previous reports 23, 34 and were documented in 9 of 38 cases with available follow-up data in this series. However, this may be an underestimate because only a minority of patients was followed beyond their acute illness. Onychomadesis associated with HFMD most often occurs 3 to 8 weeks after HFMD is diagnosed. 35, 36 It is generally asymptomatic, and the nails typically regrow normally within several months.
The demographics and systemic manifestations observed in our patients are representative of previous reports of HFMD outbreaks, with a predilection for preschool-age children of either gender, occurring primarily during the late spring to early summer. 3, 6 Fever and oropharyngeal pain were the 2 most commonly reported symptoms. The low rate of gastrointestinal and respiratory symptoms is also consistent with past reports of CVA6 HFMD. 3, 6 Overall, the extracutaneous features of the 2011-2012 HFMD outbreak appear similar to those of the most common cause of HFMD, CVA16, rather than more virulent strains such as enterovirus 71. 37 Only 10 patients in our sample were hospitalized, primarily because of the unusual nature of the skin disease. These children often received empriric antivirals and antibiotics and a diagnostic evaluation for extensive vesicles and bullae. Although a few patients did have dehydration in the setting of oral ulcerations, no patients in our study developed serious systemic complications that sometimes occur with enterovirus infections, such as myocarditis, pneumonia/pneumonitis, aseptic meningitis, or meningoencephalitis. Our report suggests that the extensive and varied cutaneous features seen in this outbreak do not portend an increased risk for severe systemic illness.
FIGURE 5
A toddler with confirmed CVA6 infection who had vesicles localized to areas of sunburn (a) in addition perianal and buttocks erosions (b).
FIGURE 6
A 4-month-old (a) and 15-month-old (b) with confirmed CVA6 infection who presented with acral bullae. Petechial and purpuric rash
• Most often seen in patients . 5 years of age
• Leukocytoclastic vasculitis
• Often acral
• Glove and stocking purpura (parvovirus infection)
Delayed cutaneous findings
• Onychomadesis (nail shedding) and Beau' s lines (tranverse grooves)
• Onychomadesis: Medication induced (tetracyclines), after severe systemic illness • Acral desquamation
• Acral Desquamation: after toxin or superantigen-mediated disease (Group A Streptococcus infection, Kawasaki disease, or toxic shock syndrome)
